Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704782 · ClinicalTrials.gov registry record · Phase 2
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
A Phase 2 study, sponsored by Medivation.
- Terminated
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00704782 is a Phase 2 study that was terminated before completion, run by Medivation. The registered enrollment target is 50 participants.
The verdict
NCT00704782, a Phase 2 study, was terminated before completion, sponsored by Medivation.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.
Interventions
- DRUG dimebon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00704782
The ClinicalTrials.gov registry entry for NCT00704782 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medivation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dimebon is the first listed.
NCT00704782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00704782 about?
NCT00704782 is a clinical study titled "Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease". The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.
What is the current status of trial NCT00704782?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2008-04. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00704782?
The interventions under investigation include: dimebon (DRUG).
Who is sponsoring clinical trial NCT00704782?
This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.